Episode 3 - Exploring Private Markets Through a Self-Directed IRA Ft. Astrocyte
Unable to add items
Sorry, we're unable to add the item because your cart is already full.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Failed to remove from Wish List.
Please try again later
Adding to library failed
Please try again
Unable to follow podcast
Unable to unfollow podcast
Episode 3 - Exploring Private Markets Through a Self-Directed IRA Ft. Astrocyte
-
Narrated by:
-
By:
Join Madison Trust for an educational conversation with William S. Korinek, Ph.D., Co-Founder and CEO of Astrocyte Pharmaceuticals, as he discusses the science and clinical research behind the company’s work in concussion, traumatic brain injury, and stroke. We’ll also explore the role Self-Directed IRAs can play in holding alternative assets, while providing an educational look at private companies, and clinical-stage drug development.
adbl_web_anon_alc_button_suppression_t1
No reviews yet
